Nexsen Limited (NXN) Share Price & Analysis

NXN Stock Chart & Stats

A$0.16-A$0.01(-5.88%)

At close: Oct 30 4:00 PM GMT+11

Day’s Range: AUD 0.16 - AUD 0.17
52-Week Range: AUD 0.11 - AUD 0.35
Previous Close: AUD 0.17
Volume: N/A
Average Volume (3M): 241.50K
Market Cap: AUD 32.32M
Enterprise Value: AUD 45.57M
Total Cash (Recent Filing): N/A
Total Debt (Recent Filing): N/A
Price to Earnings (P/E): ―
Beta: 0.69
Next Earnings: Mar 04, 2027 (Est.)
EPS Estimate: N/A
Next Dividend Ex-Date: N/A
Dividend Yield: N/A

Nexsen Limited News

Nexsen broadens GBS portfolio, builds Asia-Pacific R&D base and resets StrepSure U.S. timeline

Nexsen Limited ( ($AU:NXN) ) has issued an update. Nexsen Limited reported a pivotal quarter marked by an expanded Group B Streptococcus strategy and a deeper Asia-Pacific footprint, underscored by

4d agoNXN

Nexsen sets AGM as Asian expansion and funding bolster diagnostics push

The latest update is out from Nexsen Limited ( ($AU:NXN) ). Nexsen Limited, a newly listed ASX diagnostics company, has called its 2026 Annual General Meeting for 9 November in

3w agoNXN

Nexsen reshapes leadership to drive growth in point-of-care diagnostics

Nexsen Limited ( ($AU:NXN) ) just unveiled an update. Nexsen Limited has appointed globally recognised surgeon and healthcare leader Professor Shekhar Kumta as Executive Director, shifting him from a non-executive

1M agoNXN

Nexsen Set for ASX Trading Reinstatement Ahead of Joint Venture Update

The latest announcement is out from Nexsen Limited ( ($AU:NXN) ). Trading in Nexsen Limited shares on the ASX is set to resume immediately after the company releases an announcement

1M agoNXN

Nexsen Moves to Expand GBS Diagnostics With FlashDx Joint Venture

Nexsen Limited ( ($AU:NXN) ) has provided an announcement. Nexsen Limited has entered a non-binding term sheet with FlashDx Shenzhen Inc. to form a 50:50 joint venture to develop and

1M agoNXN

Nexsen Seeks ASX Trading Suspension Ahead of Material Device Contract Announcement

Nexsen Limited ( ($AU:NXN) ) has shared an announcement. Nexsen Limited has requested an immediate voluntary suspension of trading in its fully paid ordinary shares on the ASX under Listing

1M agoNXN

Nexsen Refines StrepSure After Interim Trial, Nudging Back U.S. FDA Timeline

Nexsen Limited ( ($AU:NXN) ) has issued an update. Nexsen Limited has halted enrollment in its Melbourne clinical study of StrepSure after a planned interim review and will incorporate real-world

1M agoNXN

Nexsen Seeks ASX Trading Halt Ahead of RAPID-GBS Trial Update

Nexsen Limited ( ($AU:NXN) ) just unveiled an announcement. Nexsen Limited, trading on the ASX as NXN, operates in the healthcare and biotechnology sector and is advancing clinical studies such

1M agoNXN

Nexsen Directors Convert Performance Rights After $2m Grant Funding Milestone

An announcement from Nexsen Limited ( ($AU:NXN) ) is now available. Nexsen Limited has confirmed that vesting conditions for its Class B Performance Rights were met after securing more than

1M agoNXN

Nexsen Issues 4 Million Long-Dated Unquoted Options

Nexsen Limited ( ($AU:NXN) ) has provided an update. Nexsen Limited has notified the market of the issue of new unquoted equity securities in the form of options as part

1M agoNXN

NXN FAQ

What was Nexsen Limited’s price range in the past 12 months?

Nexsen Limited lowest share price was AU$0.11 and its highest was AU$0.35 in the past 12 months.

What is Nexsen Limited’s market cap?

Nexsen Limited’s market cap is AU$32.32M.

When is Nexsen Limited’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Nexsen Limited’s earnings last quarter?

Nexsen Limited released its earnings results on Aug 30, 2026. The company reported -AU$0.012 earnings per share for the quarter.

Is Nexsen Limited overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does Nexsen Limited pay dividends?

Nexsen Limited does not currently pay dividends.

What is Nexsen Limited’s EPS estimate?

Nexsen Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Nexsen Limited have?

Nexsen Limited has 201,996,200 shares outstanding.

What happened to Nexsen Limited’s price movement after its last earnings report?

Nexsen Limited reported an EPS of -AU$0.012 in its last earnings report. Following the earnings report the stock price went up 12.5%.

Which hedge fund is a major shareholder of Nexsen Limited?

Currently, no hedge funds are holding shares in AU:NXN

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Nexsen Limited Stock Smart Score

Underperform

Learn more about TipRanks Smart Score

Top Smart Score Stocks >

Company Description

Nexsen Limited

Nexsen Limited operates as a nanobiotechnology company that develops proprietary biosensing platforms for rapid, high-precision point-of-care (POC) medical diagnostics and point-of-use sensing for veterinary, agricultural, and biosecurity applications. The company offers Group B Streptococcus (GBS) rapid sensor, a diagnostic for the detection of human GBS in expectant mothers; kidney diseases, a POC tests for the screening, detection, and ongoing monitoring of various subsets of acute kidney injury and chronic kidney disease; bovine mastitis, a farm diagnostic to detect mastitis early which helps farmers; biosecurity pathogen tests, a portable sensor for frontline detection of invasive pests and pathogens -built for customs officers, farmers, and quarantine zones. The company was incorporated in 2021 and is based in Sydney, Australia.

Nexsen Limited (NXN) Earnings & Revenues

Historic Earnings Reports

Technical Analysis

Overall Consensus

Indicator	Bullish	Neutral	Bearish
Overall Consensus	7	3	12
Technical Analysis	3	3	4
Moving Averages	4	0	8

Technical Analysis >

Similar Stocks

Stocks similar to AU:NXN
Company	Price & Change	Follow
AU:OSXOsteopore Ltd.
AU:1ADAdAlta Ltd.
AU:ANRAnatara Lifesciences Ltd

Compare AU:NXN Stocks >

Ownership Overview

21.68% Insiders
78.32% Public Companies and Individual Investors

Detailed Ownership Overview >

Popular Stocks

Popular Stocks
Company	Price & Change	Follow
NVDANvidia
AAPLApple
MSFTMicrosoft

NXN Stock Chart & Stats

Nexsen Limited News

Nexsen broadens GBS portfolio, builds Asia-Pacific R&D base and resets StrepSure U.S. timeline

Nexsen sets AGM as Asian expansion and funding bolster diagnostics push

Nexsen reshapes leadership to drive growth in point-of-care diagnostics

Nexsen Set for ASX Trading Reinstatement Ahead of Joint Venture Update

Nexsen Moves to Expand GBS Diagnostics With FlashDx Joint Venture

Nexsen Seeks ASX Trading Suspension Ahead of Material Device Contract Announcement

Nexsen Refines StrepSure After Interim Trial, Nudging Back U.S. FDA Timeline

Nexsen Seeks ASX Trading Halt Ahead of RAPID-GBS Trial Update

Nexsen Directors Convert Performance Rights After $2m Grant Funding Milestone

Nexsen Issues 4 Million Long-Dated Unquoted Options

NXN FAQ

Nexsen Limited Stock Smart Score

Company Description

Nexsen Limited

Nexsen Limited (NXN) Earnings & Revenues

Technical Analysis

Overall Consensus

Similar Stocks

Ownership Overview

Popular Stocks

Become an Expert with TipRanks Premium